miRNA‑344b‑1‑3p modulates the autophagy of NR8383 cells during Aspergillus fumigatus infection via TLR2

  • Authors:
    • Yuting Wu
    • Hong Xu
    • Yongqiang Li
    • Dongwei Huang
    • Lu Chen
    • Yahui Hu
    • Li Li
    • Deming Zhang
    • Wenjie Huang
  • View Affiliations

  • Published online on: May 10, 2019     https://doi.org/10.3892/etm.2019.7569
  • Pages: 139-146
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Autophagy serves a pivotal role in host defense during fungal infections, and the contribution by toll‑like receptor 2 (TLR2) has been well demonstrated. It has been reported that microRNA‑344a‑1‑3p (miR‑344a‑1‑3p) can directly target TLR2. However, the expression of TLR2 significantly decreases during Aspergillus fumigatus infection. Therefore, the specific role of miR‑344a‑1‑3p in the host defense against A. fumigatus infection remains to be elucidated. In the present study, A. fumigatus infection increased the expression of TLR2 and induced autophagy, which was indicated by increasing expression levels of autophagy‑related protein 5 (ATG5), Beclin‑1, light chain 3 (LC3)‑1 and LC3‑II, as measured by western blot analysis, and an increased number of GFP‑LC3 puncta, as measured by fluorescence. Following transfection with miR‑344a‑1‑3p mimics and/or TLR2, miR‑344b‑1‑3p significantly inhibited the expression of TLR2, Beclin‑1, ATG5, LC3‑I and LC3‑II, whereas the overexpression of TLR2 significantly attenuated the inhibitory effect on autophagy by miR‑344b‑1‑3p. Collectively, these findings demonstrate that A. fumigatus can be controlled by the induction of autophagy following de‑repression of the expression of TLR2, mediated by miR‑344a‑1‑3p.

Introduction

Human airways are subjected to constant exposure to Aspergillus fumigatus, resulting in the inhalation of several hundred spores per day (1). However, components of the innate immune system, particularly macrophages, efficiently remove A. fumigatus once the spores enter alveoli within the lungs, therefore, adverse effects are rare (24). In immunocompromised individuals, A. fumigatus has been shown to be a causative agent of multiple forms of aspergillosis, including saprophytic aspergillosis, allergic aspergillosis and invasive aspergillosis, a life-threatening systemic fungal infection (57). In addition, A. fumigatus is currently the most prevalent airborne fungal pathogen, responsible for ~90% of systemic infections (810).

The inhalation of A. fumigatus spores initiates an antifungal immune response by pattern recognition receptors (PRRs). In particular, the toll-like receptors (TLRs) are a class of PRRs that recognize pathogen-associated molecular patterns and activate the innate immune response to eliminate invading pathogens and mediate the adaptive immune response. As a member of the TLR family, TLR2 serves an important role in recognizing various Aspergillus cell wall components and modulating host defense responses, including autophagy (1113). Furthermore, TLR2 is critical to activating autophagy against fungi in macrophages (14).

Autophagy maintains cellular homeostasis through targeted degradation. Multiple roles for autophagy have been reported in the inflammatory response and the defense against infections; a recent study suggested an important role in the clearance of bacterial, viral and parasitic pathogens (15). Regarding the response to fungal infection, autophagy has been linked to several processes important to immunity, including pathogen recognition, phagocytosis, microbial killing, cytokine release, antigen presentation and inflammation regulation. Several proteins are involved in autophagy, including light chain 3 (LC3), Beclin-1 and autophagy-related protein 5 (ATG5) (1618).

Autophagy can also be regulated by microRNAs (miRNAs), a class of endogenous short, non-coding RNAs involved in the regulation of gene expression (19). Our previous study demonstrated that miR-344b-1-3p is an effective direct modulator of TLR2 (20). However, any correlation between the levels of miRNA-344b-1-3p and autophagy remain to be elucidated.

Therefore, in the present study, the expression of miRNA-344a-1-3p was observed during A. fumigatus infection, and its role and potential mechanism in regulating infection-induced autophagy by macrophages was investigated to provide a better understanding of host defense mechanisms following Aspergillus infection.

Materials and methods

Cell culture

A rat alveolar macrophage cell line, NR8383, was purchased from the Shanghai Institute of Biochemistry and Cell Biology. The cells were maintained in Ham's F-12K medium (Sigma-Aldrich; Merck KGaA) containing 15% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) at 37°C and 5% CO2.

Microbes

A. fumigatus was prepared using the air from a moisture box and cultured on 1.5% malt extract agar plates (Biokar Diagnostics; Beuvais, France) placed in the dark at 25°C for 7 days. Thee spores were harvested using a sterile loop, which were then suspended in Hank's balanced salt solution containing 0.0001% Triton X-100. The spores were counted under a light microscope using a Bürker chamber to calculate their concentration and their strain was identified using an identification service (Central Bureau of Schimmelcultures, Utrecht, Netherlands). The collected spores were stored at −20°C until use.

Exposure to A. fumigatus

The NR8383 cells were seeded in triplicate into 6-well plates (5×104 cells per well) and incubated at 37°C in an atmosphere containing 5% CO2. Following overnight culture, the cells were exposed to A. fumigatus (107 spores per well) for the indicated durations (0, 30, 45, 60, 90 or 120 min) at 37°C. Following treatment, the cells were harvested, following which total RNA was extracted and stored at −80°C until examination.

Cell transfection

The miR-344b-1-3p mimics, negative control (NC), and inhibitor were purchased from Guangzhou RiboBio Co., Ltd. (Guangzhou, China). Lipofectamine 2000 (Invitrogen; Thermo Fisher Scientific, Inc.) was used for transfection, according to the manufacturer's protocol. The NR8383 cells were seeded into 24-well plates (1×104 cells per well) and transfected with the miR-344b-1-3p mimics, NC or inhibitor to a final concentration of 25 nM. Tlr2 cDNA was cloned into the BamHI and AscI sites of the pLenti6/V5-DEST vector (Invitrogen; Thermo Fisher Scientific, Inc.). Then, 2 µl solution was added into 100 µl competence XL-BLUE Escherichia coli (Invitrogen; Thermo Fisher Scientific, Inc.) and absorbed for 15 min on ice. After being placed in a water bath for 50 sec at 42°C and rapidly cooled for 2 min on ice, the cell solution was pipetted into 1 ml LB culture medium (Merck KGaA), oscillated for 1 h at 37°C and 180 rpm and then centrifuged for 3 min 2,012.4 × g and 37°C. The pellet was mixed with 200 ml LB culture medium, coated onto the LB culture plates containing 100 µg/ml ampicillin and cultured overnight at 37°C. A total of 10 clones were picked out and inoculated in 3 ml LB culture medium. After culturing overnight at 37°C on a shaker at 250 rpm, the vectors were extracted and then verified by nucleotide sequencing by GenScript Corporation (Nanjing, China). Subsequently, the NR8383 cells were stably transfected with the vector using Lipofectamine 2000 and incubated in Ham's F-12K medium containing 0.1 mg/ml blasticidin (Invitrogen; Thermo Fisher Scientific, Inc.). The transfected cells were then cultured for 24 h prior to treatment with A. fumigatus (107 spores per well) for 60 min at 37°C, and then harvested for examination.

Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

Total RNA was extracted using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. The samples (500 ng) were reverse-transcribed into cDNA using a RevertAid First Strand cDNA Synthesis kit (Thermo Fisher Scientific, Inc.) through incubating for 5 min at 25°C followed by 60 min at 42°C. qPCR was performed using the SYBR Green PCR Master Mix kit (Takara Biotechnology Co., Ltd.), with the following steps: 95°C for 5 min, followed by 40 cycles of 95°C for 10 sec and 60°C for 40 sec. The primers for miR-344b-1-3p, Tlr2, glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and U6 were designed and obtained from Sangon Biotech Co., Ltd. (Shanghai, China). The primer sequences are listed in Table I. The expression levels of the Tlr2 mRNA and miR-344b-1-3p were normalized to Gapdh and U6, respectively, using the 2−ΔΔCt method (21).

Table I.

Primer pairs for the reverse transcription-quantitative polymerase chain reaction analysis.

Table I.

Primer pairs for the reverse transcription-quantitative polymerase chain reaction analysis.

NameForward primer (5′-3′)Reverse primer (5′-3′)
GAPDH AATGCATCCTGCACCACCAA GATGGCATGGACTGTGGTCA
U6 CGCTTCACGAATTTGCGTGTCAT GCTTCGGCAGCACATATACTAAAAT
miR-344b-1-3p GGGGTGATATAACCAAAGCC GTGCGTGTCGTGGAGTCG
TLR2 TGCAGGGACCTTTGCTATGATG ACAAAGTCCCGCTTGTGGGA

[i] miR, microRNA; TLR2, toll-like receptor 2.

Western blot assay

Western blot analysis was performed using samples from whole-cell lysates processed using a Total Protein Extraction kit (Beyotime Institute of Biotechnology; Beijing, China) and quantified with a BCA Protein Assay kit. Following heat denaturation at 95°C for 5 min, the samples of total protein (20 µg) were loaded onto sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels (5%), electrophoresed and transferred onto polyvinylidene difluoride membranes (EMD Millipore; Billerica, MA, USA). The membranes were blocked in 5% nonfat milk for 2 h at room temperature, and were then incubated overnight at 4°C with one of the following primary antibodies: TLR2 (cat. no. EPR20303; Abcam, Cambridge, MA, USA), ATG5 (cat. no. 12994), Beclin-1 (cat. no. 3738), LC3 (cat. no. 4108) and GAPDH (cat. no. 5174) from Cell Signaling Technology, Inc. (Danvers, MA, USA). The primary antibodies were used in a 1:1,500 dilution. Following washing three times with TBST, the membranes were incubated with secondary antibody in a 1:10,000 dilution (cat. no. A1949; Sigma-Aldrich; Merck KGaA) for 1 h at room temperature. Following a final wash, signal was detected using enhanced chemiluminescence reagents (GE Healthcare Life Sciences). The band intensities were quantified and normalized to GAPDH using ImageJ 1.47 software (National Institutes of Health).

Examination of autophagy by GFP-LC3 detection

The NR8383 cells were transfected in the manner described above with the inclusion of GFP-LC3 (Invitrogen; Thermo Fisher Scientific, Inc.). The cells transfected only with GFP-LC3 were incubated with A. fumigatus (107 spores per well) for the indicated duration (0, 30, 45, 60, 90 or 120 min). The co-transfected cells were incubated with A. fumigatus spores for 60 min. The cells were then incubated with DAPI (5 µg/ml; Beyotime Institute of Technology) for 10 min. Following fixing of the cells in 4% paraformaldehyde for 30 min at room temperature, the cells were visualized by confocal microscopy.

Statistical analysis

Statistical analyses were performed using SPSS (version 17.0; SPSS, Inc., Chicago, IL, USA). All data are expressed as the mean ± SEM, with each assay performed in triplicate. The statistical significance was estimated by using one-way analysis of variance followed by Bonferroni's post hoc test. P<0.05 was considered to indicate a statistically significant difference.

Results

A. fumigatus spores induce a reduction in miR-344b-1-3p and an increase in TLR2, LC-I, LC-II, beclin-1 and ATG-5

To confirm the association between miR-344b-1-3p and TLR2, their expression at the transcriptional level was determined by RT-qPCR analysis. As shown in Fig. 1A, the levels of miRNA-344b-1-3p decreased in a time-dependent manner following exposure to the spores, reaching a plateau after 90 min of treatment. By contrast, a corresponding time-dependent increase was observed in the mRNA expression of Tlr2 following exposure to the spores, reaching a plateau after 90 min of treatment (Fig. 1B). A similar effect on the protein expression of TLR2 was observed (Fig. 1C and D). These data show that the inverse correlation between the mRNA levels of Tlr2 and miR-344b-1-3p may indicate that TLR2 is a target of miR-344b-1-3p.

The immunofluorescence analysis showed that the number of GFP-LC3 puncta increased in a time-dependent manner following infection (Fig. 2), indicating that the presence of A. fumigatus spores induced autophagy time-dependently within 120 min of exposure. Furthermore, the expression levels of each of the above-mentioned proteins were negatively and positively associated with the levels of miR-344b-1-3p and TLR2, respectively. These data indicate that the expression of autophagy-related proteins and autophagy itself may be mediated by miR-344b-1-3p and TLR2.

miR-344b-1-3p significantly suppresses the autophagy induced by A. fumigatus spores

Following transfection with the NC mimic, inhibitor NC, mimics or inhibitor, the cells were exposed to A. fumigatus for 60 min to observe the effect of miR-344b-1-3p on spore-induced autophagy. The 60-min exposure time was selected to allow time for autophagy to initiate and also avoid the saturation response. To demonstrate the transfection effects of miR-344b-1-3p inhibitor or mimics, the expression of miR-344b-1-3p was measured by RT-qPCR assay. The results showed that the expression of miR-344b-1-3p was significantly increased in the miR-344b-1-3p mimics group, and was significantly decreased in the miR-344b-1-3p inhibitor group, compared with that in the NC groups, which indicates high transfection efficiency (Fig. 3A). In addition, the expression levels of ATG5, Beclin-1, LC3-1 and LC3-II were determined by western blotting. As shown in Fig. 3B, the expression levels significantly decreased following mimics treatment and significantly increased following inhibitor treatment. Similarly, the density of GFP-LC3 puncta markedly decreased and increased following treatment with mimics and inhibitor, respectively (Fig. 3C). These results indicate that miR-344b-1-3p mimics treatment significantly decreased spore-induced autophagy and that the inhibition of miR-344b-1-3p significantly increased autophagy. Consequently, miR-344b-1-3p may inhibit A. fumigatus autophagy by regulating the levels of ATG5, Beclin-1 and LC3.

Additionally, the levels of TLR2 were determined by western blot analysis; the levels were markedly decreased following mimics exposure and markedly increased following inhibitor exposure (Fig. 4A and B), indicating that TLR2 is a target of miR-344b-1-3p.

miR-344b-1-3p inhibits the autophagy induced by A. fumigatus spores by regulating TLR2

To investigate the roles of miR-344b-1-3p and TLR2 in the autophagy induced by A. fumigatus spores, cells were transfected with one of the following: Control, mimics NC, mimics, mimics + TLR2 NC, mimics NC + TLR2 and mimics + TLR2. The results from the western blot assay revealed that the expression levels of TLR2, Beclin-1, ATG5, LC3-I and LC3-II were significantly decreased in cells transfected with miR-344b-1-3p mimics compared with those in the NC group. The expression levels of TLR2, Beclin-1, ATG5, LC3-I and LC3-II were significantly increased in cells transfected with mimics NC + TLR2 compared with those in cells in the mimics NC group. The expression levels of TLR2, Beclin-1, ATG5, LC3-I and LC3-II were markedly increased in the cells transfected with mimics + TLR2 compared with those in the mimics group (Fig. 4A-F). Similarly, the number of GFP-LC3 puncta in the cells was significantly decreased following miR-344b-1-3p mimics transfection, whereas the overexpression of TLR2 markedly attenuated the inhibitory effect on autophagy by miR-344b-1-3p (Fig. 4G). Therefore, these data indicated that miR-344b-1-3p may serve an important role in Aspergillus spore-induced autophagy by regulating TLR2.

Discussion

miRNAs are critical to multiple facets of immune system function, including pathogen recognition, inflammation activation and resolution. TLR2, an important pathogen recognition receptor, is targeted and regulated by miR-344b-1-3p, however, its role in regulation of immune function remains to be elucidated. To the best of our knowledge, miR-344b-1-3p was first associated with A. fumigatus-induced autophagy in macrophages, and may act by mediating recognition of the fungus.

Accumulating evidence suggests that autophagy is closely associated with immunity. A. fumigatus infection can elicit autophagy in several types of inflammatory cell, including monocytes and macrophages, and regulate their physiological activity (22,23). Studies have shown that autophagy directly affects the production of certain cytokines by mediating transcription, processing and secretion (24). These cytokines, which include interleukin-1β (IL-1β), IFN-γ, and tumor necrosis factor (TNF)-α, in turn dampen pro-inflammatory responses (25,26). Autophagy also accelerates macrophage aging, resulting in various functional changes, including impaired maturation, decreased antigen presentation capacity and reduced innate responses, alongside increased basal production of inflammatory cytokines (27). Additionally, autophagy triggers the death of activated macrophages through a caspase-independent pathway (28). Autophagy exerts dual functionality in macrophages, pro-inflammation and anti-inflammation, to achieve host protection and intracellular pathogen elimination.

Autophagy is both provoked and regulated. In its recognition of A. fumigatus, TLR2 serves a critical role in autophagy-induction in infected macrophages (14). In RAW264.7 cells, this induction is reached by activating multiple signaling pathways, including the JNK, ERK, and PI3K signaling pathways (2931). Although the fungus used in these studies was not A. fumigatus, the same pathways were suggested to contribute to the autophagy in macrophages induced by A. fumigatus. Among the multiple functions of autophagy-induction, increased levels of pro-inflammatory cytokines have been reported. The cytokines, including IL-1β and TNF-α, can in turn upregulate autophagy, forming a positive feedback loop (24).

The ability of TLR2 to detect Aspergillus spores and induce autophagy is associated with its expression levels. Wu et al reported that induced expression of TLR2 by the fungus was noted in human corneal epithelial cells and mice macrophages (32,33). Consistent with these findings, in the present study, A. fumigatus exposure significantly increased the expression of TLR2 in rat alveolar cells, which was accompanied by the induction of autophagy and a decrease in the levels of miR-344b-1-3p. In addition, treatment with miRNA mimics in the present study attenuated the induction of TLR2 and autophagy. miR-344b-1-3p has been demonstrated to directly target TLR2 (20), suggesting a mechanism by which the miRNA may mediate autophagy. Additionally, targeting TLR2 with miR-344b-1-3p inhibited the expression of downstream genes, including TNF-α and IL-1β (20). In addition to the regulatory role of cytokines in autophagy, miR-344b-1-3p may also regulate autophagy in macrophages exposed to fungi by inhibiting cytokines. In addition to miR-344b-1-3p, miR-19 and miR-105 have been demonstrated to regulate the expression of TLR2 (34,35), indicating they may be associated with the activation of autophagy in macrophages. However, this requires confirmation by further investigations.

Taken together, the results of the present study demonstrate that the levels of miR-344b-1-3p decreased following challenge by A. fumigatus, which enhanced the activation of autophagy in infected macrophages by targeting TLR2 to protect against infection by intracellular mycobacteria. The present study reveals the importance of an miRNA in the regulation of autophagy and elimination of A. fumigatus. At present, miR-344b-1-3p has only been examined in rats. There is evidence to show that miR-344b-1-3p is an effective modulator of the TLR2 gene in COPD rats (1). It was also found that miR-344b-1-3p cannot be detected in Homo sapiens. In the future, there may be potential therapeutic interventions for saprophytic aspergillosis, allergic aspergillosis and invasive aspergillosis by artificially synthesizing miR-344b-1-3p and the targeted drugs.

Acknowledgements

Not applicable.

Funding

The present study was supported by the Natural Science Foundation of Guangdong Province (grant no 2014A030313597).

Availability of data and materials

The analyzed datasets generated during the present study are available from the corresponding author on reasonable request.

Authors' contributions

All authors designed the study. YW, HX, YL, DH performed the experiments. YW, HX, YL, LC, YH and LL collected and analyzed the data. YW wrote the manuscript. DZ and WH provided advice on the experimental design and critically revised the manuscript. All authors read and approved the final version of the manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Morton CO, Bouzani M, Loeffler J and Rogers TR: Direct interaction studies between Aspergillus fumigatus and human immune cells; what have we learned about pathogenicity and host immunity? Front Microbiol. 3:4132012. View Article : Google Scholar : PubMed/NCBI

2 

Roilides E, Sein T, Schaufele R, Chanock SJ and Walsh TJ: Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis. J Infect Dis. 178:589–592. 1998. View Article : Google Scholar : PubMed/NCBI

3 

Chotirmall SH, Al-Alawi M, Mirkovic B, Lavelle G, Logan PM, Greene CM and McElvaney NG: Aspergillus-associated airway disease, inflammation, and the innate immune response. Biomed Res Int. 2013:7231292013. View Article : Google Scholar : PubMed/NCBI

4 

Schneemann M and Schaffner A: Host defense mechanism in Aspergillus fumigatus infections. Contrib Microbiol. 2:57–68. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Segal BH and Walsh TJ: Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 173:707–717. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Weinberger M, Elattar I, Marshall D, Steinberg SM, Redner RL, Young NS and Pizzo PA: Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore). 71:24–43. 1992. View Article : Google Scholar : PubMed/NCBI

7 

Duong M, Ouellet N, Simard M, Bergeron Y, Olivier M and Bergeron MG: Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis. 178:1472–1482. 1998. View Article : Google Scholar : PubMed/NCBI

8 

Bodey GP and Vartivarian S: Aspergillosis. Eur J Clin Microbiol Infect Dis. 8:413–437. 1989. View Article : Google Scholar : PubMed/NCBI

9 

Kurup VP and Kumar A: Immunodiagnosis of aspergillosis. Clin Microbiol Rev. 4:439–456. 1991. View Article : Google Scholar : PubMed/NCBI

10 

Latgé JP: Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 12:310–350. 1999. View Article : Google Scholar : PubMed/NCBI

11 

Bellocchio S, Montagnoli C, Bozza S, Gaziano R, Rossi G, Mambula SS, Vecchi A, Mantovani A, Levitz SM and Romani L: The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol. 172:3059–3069. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Mambula SS, Sau K, Henneke P, Golenbock DT and Levitz SM: Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem. 277:39320–39326. 2002. View Article : Google Scholar : PubMed/NCBI

13 

Chai LY, Kullberg BJ, Vonk AG, Warris A, Cambi A, Latgé JP, Joosten LA, van der Meer JW and Netea MG: Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun. 77:2184–2192. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Anand PK, Tait SW, Lamkanfi M, Amer AO, Nunez G, Pagès G, Pouysségur J, McGargill MA, Green DR and Kanneganti TD: TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J Biol Chem. 286:42981–42991. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Kanayama M and Shinohara ML: Roles of autophagy and autophagy-related proteins in antifungal immunity. Front Immunol. 7:472016. View Article : Google Scholar : PubMed/NCBI

16 

Tanida I, Ueno T and Kominami E: LC3 and autophagy. Methods Mol Biol. 445:77–88. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Kang R, Zeh HJ, Lotze MT and Tang D: The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18:571–580. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Mihalache CC and Simon HU: Autophagy regulation in macrophages and neutrophils. Exp Cell Res. 318:1187–1192. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X, Liu CG and Yang JM: Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy. 5:816–823. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Xu H, Wu Y, Li L, Yuan W, Zhang D, Yan Q, Guo Z and Huang W: MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway. Int J Chron Obstruct Pulmon Dis. 12:627–638. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Xu H, Fei D, Zong S and Fan Z: MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5. Am J Transl Res. 8:2620–2630. 2016.PubMed/NCBI

22 

Kyrmizi I, Gresnigt MS, Akoumianaki T, Samonis G, Sidiropoulos P, Boumpas D, Netea MG, van de Veerdonk FL, Kontoyiannis DP and Chamilos G: Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling. J Immunol. 191:1287–1299. 2013. View Article : Google Scholar : PubMed/NCBI

23 

de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, Begun J, Plantinga TS, Joosten LA, van der Meer JW, et al: IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci USA. 111:3526–3531. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Harris J: Autophagy and cytokines. Cytokine. 56:140–144. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Harris J, Hartman M, Roche C, Zeng SG, O'Shea A, Sharp FA, Lambe EM, Creagh EM, Golenbock DT, Tschopp J, et al: Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 286:9587–9597. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Crisan TO, Plantinga TS, van de Veerdonk FL, Farcaş MF, Stoffels M, Kullberg BJ, van der Meer JW, Joosten LA and Netea MG: Inflammasome-independent modulation of cytokine response by autophagy in human cells. PLoS One. 6:e186662011. View Article : Google Scholar : PubMed/NCBI

27 

Stranks AJ, Hansen AL, Panse I, Mortensen M, Ferguson DJ, Puleston DJ, Shenderov K, Watson AS, Veldhoen M, Phadwal K, et al: Autophagy controls acquisition of aging features in macrophages. J Innate Immun. 7:375–391. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Xu Y, Kim SO, Li Y and Han J: Autophagy contributes to caspase-independent macrophage cell death. J Biol Chem. 281:19179–19187. 2006. View Article : Google Scholar : PubMed/NCBI

29 

Fang L, Wu HM, Ding PS and Liu RY: TLR2 mediates phagocytosis and autophagy through JNK signaling pathway in Staphylococcus aureus-stimulated RAW264.7 cells. Cell Signal. 26:806–814. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Lu Z, Xie D, Chen Y, Tian E, Muhammad I, Chen X, Miao Y, Hu W, Wu Z, Ni H, et al: TLR2 mediates autophagy through ERK signaling pathway in Mycoplasma gallisepticum-infected RAW264.7 cells. Mol Immunol. 87:161–170. 2017. View Article : Google Scholar : PubMed/NCBI

31 

Shen Y, Kawamura I, Nomura T, Tsuchiya K, Hara H, Dewamitta SR, Sakai S, Qu H, Daim S, Yamamoto T and Mitsuyama M: Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infect Immun. 78:2857–2867. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Wu J, Zhang Y, Xin Z and Wu X: The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis. Mol Immunol. 64:235–243. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Reza KA, Noushin S, Zuhair H, Mehdi M, Ali AA, Majid T, Hojjatollah S and Hoseinali EM: Evaluation of the expression of TLR-2, Dectin-1 and TNF-α level in invasive aspergillosis in cancer mice. Comparative Clin Pathol. 19:601–605. 2010. View Article : Google Scholar

34 

Philippe L, Alsaleh G, Suffert G, Meyer A, Georgel P, Sibilia J, Wachsmann D and Pfeffer S: TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. J Immunol. 188:454–461. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, Stathopoulou P, Knudsen TB and Kinane DF: Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem. 284:23107–23115. 2009. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July-2019
Volume 18 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu Y, Xu H, Li Y, Huang D, Chen L, Hu Y, Li L, Zhang D and Huang W: miRNA‑344b‑1‑3p modulates the autophagy of NR8383 cells during Aspergillus fumigatus infection via TLR2. Exp Ther Med 18: 139-146, 2019
APA
Wu, Y., Xu, H., Li, Y., Huang, D., Chen, L., Hu, Y. ... Huang, W. (2019). miRNA‑344b‑1‑3p modulates the autophagy of NR8383 cells during Aspergillus fumigatus infection via TLR2. Experimental and Therapeutic Medicine, 18, 139-146. https://doi.org/10.3892/etm.2019.7569
MLA
Wu, Y., Xu, H., Li, Y., Huang, D., Chen, L., Hu, Y., Li, L., Zhang, D., Huang, W."miRNA‑344b‑1‑3p modulates the autophagy of NR8383 cells during Aspergillus fumigatus infection via TLR2". Experimental and Therapeutic Medicine 18.1 (2019): 139-146.
Chicago
Wu, Y., Xu, H., Li, Y., Huang, D., Chen, L., Hu, Y., Li, L., Zhang, D., Huang, W."miRNA‑344b‑1‑3p modulates the autophagy of NR8383 cells during Aspergillus fumigatus infection via TLR2". Experimental and Therapeutic Medicine 18, no. 1 (2019): 139-146. https://doi.org/10.3892/etm.2019.7569